EXCLUSIVE: Lessons Learned At The Benzinga 2022 Psychedelics And Cannabis Capital Conferences

Benzinga, a large content provider to brokerages and news outlets, hosts live conferences to recognize disruptive innovation in finance and technology, trading, and emerging assets.

Two of those events – ’s Psychedelics and Cannabis Capital conferences – happened last week, in person at the Fontainebleau Miami Beach.

In attendance were the likes of investors Kevin O’Leary and Tim Seymour, NBA player Lamar Odom, Tyson 2.0’s Mike Tyson and Ric Flair, among many more.

Here’s the scoop on what the event had to offer.

The Lessons Learned: founder and CEO Jason Raznick, who just sold a majority stake in to Beringer Capital, which he launched in his basement in 2010 and is backed by Dan Gilbert, kicked off the event with a keynote featuring Kevin O’Leary.

“This sector is medicine: FDA-approved, non-recreational use,” Benzinga’s Dustin Blitchok quoted O’Leary saying during a speech on psychedelics in mental health treatment.

O’Leary is a staunch proponent of the medicine and an early backer of MindMed Inc (NASDAQ: MNMD) which he thinks is a leader given the number of trials it is engaged in.

“It’s a once-in-a-lifetime opportunity, … [and] I think Big Pharma’s starting to look at it.”

Graphic: Benzinga CEO Jason Raznick, left, and "Shark Tank" judge Kevin O'Leary at the Benzinga Psychedelics Capital Conference Tuesday at the Fontainebleau in Miami Beach, Florida. Photo …

Full story available on Benzinga.com

More EXCLUSIVE: Lessons Learned At The Benzinga 2022 Psychedelics And Cannabis Capital Conferences